a company at the crossroads
of Biotechnology and Molecular
Save millions of lives
by delivering diagnostic
results in 3 hours
Detect and identify 99%
of sepsis pathogens at species level
with revolutionary sensitivity
Sepsis in numbers
people affected annually1
Targeted specific microbial therapy shall be engaged within first hours, whereas blood cultures deliver results in 1-10 days6
in the US2
annually affected people1
Targeted specific microbial therapy shall be engaged within first hours, whereas blood culture deliver results in 1-10 days6
1. World Health Organization https://www.who.int/sepsis/en/
2. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2013 (MAY 2016) HCUP Statistical Brief #204
OCEAN offers a patented multiplexing molecular diagnostics kit.
Results in less than 3 hours
Revolutionary sensitivity of 0.3 cell/ml of blood
Drop mortality from 35% to 5 %, saving millions of lives worldwide
Healthcare cost reduction
Better antimicrobial management, avoiding drug resistance
The Start-up OCEAN Dx, specialised in the in vitro diagnostic of infectious diseases (Bordeaux, France), won the i-Nov 2020 contest organized by the French General Secretary for Investment. The 400 000 € prize will help OCEAN Dx to automate its ultra-fast diagnostic...
The Start-up OCEAN Dx, specialised in infectious diseases in vitro diagnostic (Bordeaux, France), won the i-Lab 2020 contest organized by the French Ministry of Higher Education, Research, and Innovation. The 250 000 € prize will enable OCEAN Dx to complete its...
OCEAN Dx receives €202k non-dilutive funding from Region Nouvelle-Aquitaine to create its first product prototype.